RxDoctor Payments DataLook up a doctor →

Timothy Shapiro, MD

Interventional Cardiology · Wynnewood, PANPI 1285630566

Payments from drug & device makers

$246,196in general payments, 2019–2025

Across 486 payments — averaging $506.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$95K
  • AbbVie$67K
  • Philips North America LLC$44K
  • Astrazeneca UK Limited$19K
  • Medtronic$5K
  • Boston Scientific$5K
  • plus $10K from 27 others
$3,150in research payments, 2019–2025

Across 1 payment — averaging $3150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$246,196 in reported general payments places this provider in the 85th percentile of 281 interventional cardiology providers in Pennsylvania.

See all interventional cardiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$465,510
Medicare patients
1,542
Services billed
5,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Wynnewood

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →